Annotation Detail

Information
Associated Genes
KITLG
Associated Variants
KITLG EXPRESSION
Source Database
MMMP
Description
Uveal melanoma. In this phase II trial of imatinib for the treatment of advanced uveal melanoma, no objective response was observed, despite the fact that c-KIT was overexpressed in 55% of primary tumors and in 76% of metastatic samples (no KIT mutations found), and SCF was overexpressed in 43% of primary tumors and in 58% of metastatic samples
MMMP State
expressed
MMMP Molecule
SCF
MMMP Relationship
no relationship with
MMMP Drug
Imatinib
MMMP Drug Alias
Gleevec (R)
MMMP Model
5
MMMP Reference
Hofmann UB, Clin Cancer Res 2009, 15:324-9
MMMP DNA/mRNA/Protein
protein
Drugs
Drug NameSensitivitySupported
ImatinibResitance or Non-Reponsetrue